[Federal Register Volume 72, Number 50 (Thursday, March 15, 2007)]
[Notices]
[Page 12177]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-4743]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Cooperative Agreement to the Medical Research Council 
of South Africa for TB Control and HIV Prevention, Care and Treatment 
Activities, Program Announcement (PA) Number PS07-006

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting of the aforementioned Special 
Emphasis Panel.

    Time and Date: 1 p.m.-2:30 p.m., May 11, 2007 (Closed).
    Place: Teleconference. Corporate Square, Building 8, Conference 
Room 6B.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Pub. L. 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of a research application in response to 
PA PS07-006, ``Cooperative Agreement to the Medical Research Council 
of South Africa for TB Control and HIV Prevention, Care and 
Treatment Activities.''
    For Further Information Contact: J. Felix Rogers, Scientific 
Review Administrator, Centers for Disease Control and Prevention, 
1600 Clifton Road, NE., MS E05, Atlanta, GA 30333, telephone 
404.639.6101.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 8, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-4743 Filed 3-14-07; 8:45 am]
BILLING CODE 4163-18-P